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Abstract
Objective: Evaluate the applicability of mean percentage from the predicted value of respiratory muscle 
strength (maximal inspiratory pressure-MIP; maximal expiratory pressure-MEP), as (% MIP + % MEP)/2, as 
well as the peak expiratory flow (% PEF) preoperatively, as part of a surgical risk scale for predicting the risk 
of postoperative pulmonary complications (PPC). Methods: Data on patients undergoing elective surgery of 
chest, abdomen and limbs were assessed preoperatively using the items and the scoring system proposed 
by the Torrington and Henderson, and replacing spirometry by the mean values of both (% MIP + % MEP)/2 
and % PEF. Results: The proposed scale applied to 108 patients with a mean age of 55.2 ± 14.0 presented 
PPC rate of 37.0% (p = 0.0001), of which 20.0% were classified as high risk (HR), and 62.5% moderate risk 
(MR). The mean value of respiratory muscle strength showed a statistically significant correlation with PPC 
(p = 0.000). Conclusion: The proposed scale allowed the appropriate stratification of patients at risk for 
development of PPC. The use of the mean values of (% MIP + % MEP)/2 and % PEF based on the predicted 
values can be easily applied, making spirometry unnecessary. 
 [P]
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Resumo
Objetivo: Avaliar a aplicabilidade da média do percentual do valor predito das forças musculares respira-
tórias (pressão inspiratória máxima-PImax; pressão expiratória máxima-PEmax), sendo % PImax + % PEmax/2, 
e do pico de fluxo expiratório (% PFE) no pré-operatório, como parte de uma escala de risco cirúrgico para 
predizer o risco de complicação pulmonar pós-operatória (CPP). Métodos: Dados de pacientes submetidos 
à cirurgia eletiva de tórax, abdômen e membros foram analisados no pré-operatório utilizando os itens e a 
pontuação proposta pela escala de Torrington e Henderson, e substituindo a espirometria pela média do % 
PImax + % PEmax / 2 e do % PFE. Resultados: Na escala proposta aplicada a 108 pacientes com idade média de 
55,2 ± 14,0 a taxa de CPP foi de 37,0% (p = 0,0001), onde 20,0% foram classificados como de alto risco (RA) e 
62,5% risco moderado (RM). O percentual da média da força muscular respiratória apresentou uma correla-
ção significante em relação à CPP na escala proposta (p = 0,000). Conclusão: A escala proposta permitiu 
estratificar de maneira adequada pacientes com risco de CPP. A utilização da média do % PImax + % PEmax / 
2 e do % PFE, baseados nos valores preditos, podem ser facilmente aplicáveis, tornando-se desnecessária a 
realização da espirometria.[K]
Palavras-chave: Complicações pós-operatórias. Músculos respiratórios. Laparotomia. Toracotomia.
Introduction
Postoperative pulmonary complications (PPC), es-
pecially in abdominal and thoracic surgeries, besides 
having high rates of morbidity and mortality, extend 
hospital stay and consequently increase costs to the 
health care (1).The prevention of PPCs has motivated 
numerous studies aimed at validating indices to pre-
dict surgical risks (2, 3). 
The scoring system devised by Torrington and 
Henderson (4), which used spirometry associated with 
other risk factors of PPC was validated in 2000 (5).
The conclusion was that the scale was able to esti-
mate the probability of PPCs and mortality in three 
categories: high risk (HR), moderate risk (MR), and 
low risk (LR). However, spirometry, highly recognized 
in the 1970s and 80s (6), currently has been more 
advantageous for patients undergoing pulmonary 
resection (7) or presenting respiratory symptoms (8).
Some authors found that patients with decreased 
respiratory muscle strength (MIP and MEP) are at 
increased risk of developing PPC (9, 10).
Other authors have also suggested the inclusion of 
MEP in the risk scale proposed for patients undergo-
ing cardiac surgery (11).
The present research suggests that considering 
the items evaluated as risk factors and the Torrington 
and Henderson scale, and replacing spirometry by 
both the predicted values MIP and MEP (% MIP + % 
MEP)/2, and the predicted peak expiratory flow (% 
PEF) in the preoperative period, the resulting scores 
can predict the risk of PPCs in patients undergoing 
elective surgery of the chest, abdomen and limbs.
Methods
After approval of the present project by the 
Research Ethics Committee of the Irmandade Santa 
Casa de Londrina, Parana State, Brazil (CEP 266/07), 
and after signed the consent form, a cross-sectional 
study was carried out, quantitative and observa-
tional, following the criteria established by the 
Strengthening the Reporting of Observational Studies 
in Epidemiology (Strobe) (12). 
From October 2007 to February 2009, consecu-
tive patients undergoing surgery with surgical 
incision in the chest, in abdominal or peripheral 
wall were evaluated at the Hospital Santa Casa de 
Londrina (HSCL), Londrina, Parana State, Brazil. 
Candidates who had some complications leading 
to emergency surgery, patients undergoing cardiac 
surgery, and laparoscopic surgery were excluded 
from the sample.
Of the 147 patients referred for preoperative eval-
uation, 39 (26.5%) were not included in the study. 
Of these, 19 did not undergo the surgery proposed 
by changing the therapeutic approach, five refused 
to participate in the study, nine were discharged 
without performing surgery, four patients died in 
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the preoperative stage, and two died during the sur-
gical procedure.
All patients were evaluated by a single observer in 
the preoperative stage and monitored until hospital 
discharge or death. The evaluator did not provide 
patient data for physiotherapists and even for the 
surgical team. All individuals were attended as rou-
tine patients by physiotherapy service at HSCL.
Both the clinical history and physical examination 
were assessed by a standardized questionnaire, with 
the following settings: a) high or low thoracic and 
abdominal surgery referred to surgery with surgi-
cal incision in the chest, in abdominal wall, above or 
below the umbilicus, with intracavitary manipulation, 
while peripheral referred to the extremity surgery; 
b) smoker was defined as any individual who had 
smoked any type or quantity of tobacco for at least six 
months during the survey (13); c) respiratory symp-
tomatic patient presenting acute or chronic cough 
and / or expetoration at the time of evaluation (2); 
d) lung disease referred to the evolution of chronic 
lung disease, symptomatic, with current treatment 
or not, and diagnosis previously established (14) .
Respiratory muscle strength of the participants 
was assessed by measuring the maximal inspiratory 
pressure (MIP) and the maximal expiratory pressure 
(MEP), using an analog manometer (GERAR®, with 
scale of -200 to +200 cm H2O, capsule type sensor and 
spigot type connection). The examination for collect-
ing data met the international standards established 
by the American Thoracic Society (2000) (15). To 
measure the MIP, the patient was asked to perform a 
forced inspiration from residual volume. For MEP, the 
subject was instructed to perform a maximal forced 
expiration from total lung capacity. All maneuvers 
were maintained for at least two seconds. The val-
ues obtained were compared to the table of normal-
ity for the Brazilian population (16), and expressed 
as percentage.
For PEF, a Peak Flow Meter (NCS) was used. The 
measurement was performed with the patient in sit-
ting position, head erect, mouthpiece between the 
teeth and on the tongue. The patient was instructed 
to make a deep breath and then a forced expiration to 
analyze the expiratory flow (l/ min). The highest val-
ue of three consecutive measurements was recorded 
as technically correct measured value, and additional 
measurements were performed when the two high-
est values of three maneuvers presented difference 
of more than 40 L/min. The values were compared 
with the predicted values of PEF for adults (17), and 
expressed as percentage (%PEF).
At the end of the preoperative evaluation, each 
patient was classified in relation to the risk of devel-
oping PPC, according to the classification proposed 
by the Torrington and Henderson scale (HR – 0 to 3 
points, MR – 4 to 6 points, LR – 7 to 11 points), but 
replacing the spirometry by the mean predicted value 
of MIP and MEP (% MIP + MEP)/2 and the predicted 
PEF (% PEF) (4) (Table 1).
In the postoperative period, daily monitoring of 
each patient was performed during the immediate 
postoperative period until hospital discharge or oc-
currence of death. The following definitions were 
considered as PPC: a) acute respiratory infection, 
patients who had radiological signs of pulmonary 
consolidation, body temperature > 38 °C, increased 
number of circulating leukocytes > 25% baseline 
number; tracheobronchitis was diagnosed with in-
creasing amounts or purulent tracheobronchial se-
cretion by normal chest radiography (18); b) atelecta-
sis evidenced by chest radiography and with obvious 
clinical symptoms of acute respiratory symptom (2); 
c) acute respiratory failure, clinical picture resulting 
from the exchange pulmonary gas, acutely deficient 
requiring mechanical ventilation (2); d) endotracheal 
intubation or mechanical ventilation for more than 
48 hours for treatment of acute respiratory failure, 
or need to aspiration of tracheobronchial secretion 
(2); e) bronchospasm characterized by wheezing on 
auscultation associated with acute respiratory symp-
toms and the necessity of drug therapy (2) .
In patients who died, it was investigated by clini-
cal, laboratory and medical inference data whether 
the causes were pulmonary origin. The causes of 
death of pulmonary origin were summarized into two 
major groups: 1) sepsis after pulmonary infection, 
when the inflammation was linked to a pulmonary 
infectious process in which hemodynamic instability 
emerged, unresponsive to volume replacement, de-
pendence on vasoactive drugs, related to functional 
failure of at least two major organ systems(19); 2) 
acute respiratory failure.
Data were tested for normal distribution using 
the Kolmogorov-Smirnov test. Categorical variables 
were presented as absolute numbers and propor-
tions, and the continuous variables as mean and 
standard deviation (± SD). Student’s t test and Chi-
square (X2) were used to compare the presence or 
absence of PPC, and Spearman correlation was used 
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to correlate the PPC with the risk factors and the 
proposed scale (rs). Data were analyzed using the 
Statistical Package for Social Science (SPSS 17.0) at 
p < 0.05 significance level.
Results
One hundred and eight patients were studied, of 
whom 55 were male (50.9%). The mean age was 56.2 
± 14.0 years with an age range of 19-82 years. Among 
the patients, 30 were aged > 65 years (27.8%), nine 
had a body mass index (BMI) > 30 kg/m2 (8.3%), 26 
were smokers (24.1%), 35 were symptomatic respi-
ratory patients at the time of surgery (32.4%), and 18 
had chronic lung disease (16.7%). Sixty-eight patients 
(63%) underwent thoracic surgery. The mean pre-
dicted value for MIP in the preoperative period was 
62.2 ± 23.1, while MEP and PEF were 71.5 ± 25.8, and 
Table 1 - Classification of the risk for PPC, based on the Torrington and Henderson scale (TH) with modifications, replacing 
spirometry by PEF and manovacuometry
Risk Factors Points
Age over 65 years 1
Overweight (BMI above 30) 1
Surgical site: 
thoracic 
abdominal 
other
2
2
1
Pulmonary story: 
current smoker 
cough and expectoration 
pulmonary disease
1
1
1
Peak expiratory fl ow (PEF) and manovacuometry:
PEF <50% predicted
% mean predicted value ((MIP + MEP)/2): 65.0 to 74.9%
% mean predicted value ((MIP + MEP)/2): 40.0 to 64.9%
% mean predicted value ((MIP + MEP)/2): less than 40.0%
1
1
2
3
Classification of risks for complications and mortality
Points Risk 
0 – 3
4 – 6 
7 – 11 
low 
moderate 
high
Note: PEF: peak expiratory fl ow; MIP: maximal inspiratory pressure; MEP: maximal expiratory pressure.
Source: Research data.
61.3 ± 24.5, respectively. Regarding the risk of PPC, 
43 patients (39.8%) were classified as LR, 51 as MR, 
and 14 as HR (13%) (Table 2).
Table 3 shows the relationship of the CPPs in 
patients according to the number of diagnoses. The 
most common event was the acute respiratory infec-
tion followed by tracheobronchitis occurring in 29 
patients (29/108; 26.9 %). 
Although the CPPs was observed in 40 patients 
(40/108; 37%), of the patients classified as HR 
(14/108; 13.0%), 57.1% had CPPs (p = 0.000), and 
71.4% died (p = 0.001) (Table 4).
There was a statistically significant correlation 
between the risk classification and PPC in the patients 
under study (p = 0.000). However, Table 5 shows that 
only the parameters surgical site, chronic lung dis-
ease (p = 0.020), % PEF < 50% (p = 0.000), and (% 
MIP + % MEP) / 2 < 75% (p = 0.000) were significant 
in relation to PPC (Table 5).
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Table 2 - Characteristics of the patients (n=108)
Characteristics Results p
Age (years) (mean ± SD)
(Range)
56.2 ± 14.0
(19 – 82)
0.997
Age over 65 years – n (%)
Yes
No
30 (27.8)
78 (72.2)
0.000
Gender - n (%)
male
female
55 (50.9)
53 (49.1)
1.000
BMI (Kg/m2) - (mean ± SD)
(Range)
26.5 ± 7.2
(18 – 61)
0.081
BMI above 30Kg/m2
Yes
No
09 (8.3)
99 (91.7)
0.000
Current smoker - n (%)
Yes
No
26 (24.1)
82 (75.9)
0.000
Respiratory symptoms (preop) (cough / expectoration) – n (%)
Yes
No
35 (32.4)
73 (67.6)
0.000
Previous lung disease (preop) – n (%)
Yes
No
18 (16.7)
90 (83.3)
0.000
Surgical site – n (%)
thoracic
upper abdominal
other
68 (63.0)
20 (18.5)
20 (18.5)
0.000
% of the predicted maximal inspiratory pressure (MIP) (preop) - (mean ± SD) 62.2 ± 23.1 0.000
% of the predicted maximal expiratory pressure (MEP) (preop) - (mean ± SD) 71.5 ± 25.8 0.000
% of the predicted peak expiratory fl ow (PEF) (preop) - (mean ± SD) 61.3 ± 24.5 0.000
% of the predicted peak expiratory fl ow (PEF) (preop)> 50%
Yes
No
39 (36.1)
69 (63.9)
<0.001
Risk of PPC
low 
moderate 
high
43 (39.8)
51 (47.2)
14 (13.0)
0.004
Note: SD: standard deviation; DI: interquartile range; Preop: preoperative; PO: postoperative; PPC: postoperative pulmonary complications.
Source: Research data.
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Table 3 - Distribution of PPCs observed while monitoring of patients
Type of PPC Number of patients (%)
Acute respiratory infection and tracheobronchitis 29 (26.9)
Bronchospasm 13 (12.0)
Acute respiratory failure 09 (8.3)
Reintubation 08 (7.4)
Atelectasis 04 (3.7)
Prolonged mechanical ventilation (> 48 hours) 04 (3.7)
Source: Research data.
Table 4 - Distribution of patients (n = 108) with respect to the risk of PPC and the occurrence of death and hospital discharge
Risk of PPC
N (%)
p
Low 
(LR)
N=43 
(39.8)
Moderate 
(MR)
N=51 
(47.2)
High 
(HR)
N=14
(13.0)
Total 
N=108 
(100.0)
PPC
Yes
No
07 (16.3)
36 (83.7)
25 (49.0)
26 (51.0)
08 (57.1)
06 (42.9)
40 (37.0)
68 (63.0)
0.000
Occurrence
High
Death
43 (100.0)
00 (0.0)
46 (90.2)
05 (9.8)
10 (71.4)
04 (28.6)
99 (91.7)
09 (8.3)
0.001
Note: PPC: postoperative pulmonary complications.
Source: Research data.
Table 5 - Distribution of PPC with respect to the items evaluated on the scale proposed
Pulmonary complications
Variables Yes (n=40) No (n=68) p
Age over 65 years 13 (32.5) 17 (25.0) 0.405 c
Overweight (BMI above 30) 06 (15.0) 04 (5.9) 0.117 c
Surgical site
Thoracic
Upper abdominal
Peripheral
25 (62.5)
12 (30.0)
03 (7.5)
43 (63.2)
08 (11.8)
17 (25.0)
0.000 c
Current smoker 06 (15.0) 20 (29.40) 0.092 c
Cough / expectoration 13 (32.5) 22 (32.4) 0.998 c
Previous lung disease 11 (27.5) 07 (10.3) 0.020 c
PEF <50% predicted 23 (57.5) 16 (23.5) 0.000 c
(To be continued)
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thoracic surgery, which increases the risk of morbid-
ity and postoperative mortality (25). The cases of 
death were considered PPCs as they occurred due 
to pulmonary complications, which are in agreement 
with others authors (2, 10). 
Age above 65 years was not significantly correlat-
ed with PPC. In agreement with this result, other au-
thors (26) concluded that advanced age alone was not 
a risk factor for the increased PPC rate, once mortality 
and morbidity were more associated to the effects of 
aging on lung function, such as decreased lung elastic-
ity, compliance and volumes, reduced arterial oxygen 
pressure (PaO2), reduced upper airway reflexes, and 
patient's clinical condition than the chronological age.
In recent decades, obesity, defined as BMI ≥ 30 
kg/m2 has grown in epidemic form in modern soci-
ety. Obese individuals are susceptible to ineffective 
cough, atelectasis at the lung bases, and progressive 
hypoxemia, allowing installation of secretions and 
infections (27). In our study, obesity alone did not 
correlate with PPC, disagreeing with the results of 
previous studies. However, recently, the impact of 
obesity was assessed in a large cut to evaluate pa-
tients undergoing coronary intervention, and the 
findings showed that BMI ≥ 30 kg/m2 did not influ-
ence the rate of adverse clinical events (28, 29). 
Discussion
Respiratory muscle dysfunction has been shown 
as an impact factor in the evolution of various clinical 
situations and surgical conditions (10, 20). Therefore, 
the main issue and goal of the present study was to 
evaluate whether the mean predicted value in respi-
ratory muscle strength (% MIP + % MEP)/2 and the 
peak expiratory flow (% PEF) could replace spirom-
etry, stratifying the surgical risk in our population. 
The incidence of PPC found in our sample was 
37.0%. This value is close to the mean found in other 
studies, whose values were around 30.0% (21, 22). 
However, this difference may be due to the previous 
studies considered PPC only the situations leading 
to clinical manifestations such as pneumonia and 
acute respiratory failure, by increasing morbidity 
and postoperative mortality. However, it is known 
that any pulmonary complications should be con-
sidered important since often there is a connection 
between them, given that patients who develop acute 
respiratory failure initially present tracheobronchitis 
or atelectasis. 
The overall mortality rate in our study was 8.3%. 
This value is above that found in other studies (23, 
24). This may be due to 63.0% patients underwent 
Table 5 - Distribution of PPC with respect to the items evaluated on the scale proposed
Pulmonary complications
Variables Yes (n=40) No (n=68) p
Mean respiratory muscle strength 
(% MIP + % MEP)/2 (% predicted value)
> 75%
65 to 74.9
40 to 64.9
< 39.9
05 (12.5)
00 (0.0)
26 (65.0)
09 (22.5)
41 (60.3)
03 (4.4)
20 (29.4)
04 (5.9)
0.000 c
Risk of PPC
Low
Moderate
High
07 (17.5)
25 (62.5)
08 (20.0)
36 (52.9)
26 (38.2)
06 (8.8)
0.001 c
Occurrence
High
Death
31 (77.5)
09 (22.5)
68 (100.0)
00 (0.0)
0.000 c
Note: c: Spearman correlation.
Source: Research data.
(Conclusion)
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The scores assigned to each of the variables for 
the proposed scale was based on the Torrington and 
Henderson scoring system (4), which were estab-
lished empirically without statistical basis. In our 
study, the vast majority of patients (63%) underwent 
thoracotomy. This fact may lead us to assume that the 
results reflect more what happens in thoracic proce-
dures. However, considering the applicability of the 
scale, we observe that the type of surgical procedure 
and the presence of chronic lung disease contem-
plated three points, reaching the limit for LR. Added 
to the 32.4% patients with respiratory symptoms, 
as is common in this population, the scale gets one 
more point, placing it in the MR range, justifying the 
prevalence of the classification of our study. Some 
limitations were found in the present study, including 
the classification of diagnoses of primary diseases 
leading patients to the surgical procedure, especially 
the thoracotomy and upper abdominal surgery, once 
certain diseases such as cancer exposes the body to 
some degree of chronic inflammation with local and/
or systemic consequences. Another limitation was 
that the high and low abdominal surgeries have not 
been studied separately. 
Conclusion
 
The proposed scale allowed to adequately stratify 
patients at risk of PPC. The use of both the mean val-
ues of respiratory muscle strength and PEF based on 
the predicted values can be globalized and easily ap-
plied, making spirometry unnecessary. These results 
may guide health professionals working with risk 
assessment for PPCs. In addition, they could allow 
standardization of procedures and comparison of 
results between services with the same profile.
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